切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2019, Vol. 13 ›› Issue (02) : 141 -143. doi: 10.3877/cma.j.issn.1674-3946.2019.02.011

所属专题: 文献

论著

胃癌患者术前中性粒细胞淋巴细胞比、血小板淋巴细胞比对淋巴结转移预测价值
黄涛1,(), 唐钢2   
  1. 1. 636000 四川巴中,巴中市中医院外二科
    2. 636000 四川巴中,巴中市中医院普外二科
  • 收稿日期:2018-09-18 出版日期:2019-04-26
  • 通信作者: 黄涛

Clinical analysis of preoperative neutrophil/lymphocyte ratio and platelet / lymphocyte ratio in predicting lymphnodes metastasis of patients with gastric cancer

Tao Huang1,(), gang Tang2   

  1. 1. The second department of surgery, Bazhong Hospital of Traditional Chinese Medicine, Sichuan 636000, China
    2. The second department of general surgery, Bazhong Central Hospital, Sichuan636000, China
  • Received:2018-09-18 Published:2019-04-26
  • Corresponding author: Tao Huang
  • About author:
    Corresponding author: Huang Tao, Email:
  • Supported by:
    Clinical Medicine Grant of Sichuan Health and Planning Commission(No.L2016028)
引用本文:

黄涛, 唐钢. 胃癌患者术前中性粒细胞淋巴细胞比、血小板淋巴细胞比对淋巴结转移预测价值[J/OL]. 中华普外科手术学杂志(电子版), 2019, 13(02): 141-143.

Tao Huang, gang Tang. Clinical analysis of preoperative neutrophil/lymphocyte ratio and platelet / lymphocyte ratio in predicting lymphnodes metastasis of patients with gastric cancer[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2019, 13(02): 141-143.

目的

分析胃癌患者术前中性粒细胞淋巴细胞比(NLR)、血小板淋巴细胞比(PLR)对淋巴结转移预测价值。

方法

回顾性分析2016年1月至2018年6月行手术治疗的103例胃癌患者的临床病例资料,按病理结果分为淋巴结转移组(39例,转移组)与淋巴结无转移组(64例,对照组);采用SPSS20.0软件进行数据分析,术前各炎症指标和NLR、PLR等定量资料采用(±s)表示,独立t检验;TNM分期等计数资料行χ2检验;绘制ROC曲线图,计算NLR、PLR的临界值。以P<0.05表示差异具有统计学意义。

结果

术前两组白细胞计数差异无统计学意义(P=0.156);但术前淋巴结转移组患者中性粒细胞、血小板、淋巴细胞高于对照组,两组差异有统计学意义(P=0.037, 0.044, 0.047);术前淋巴结转移组患者NLR、PLR明显高于对照组(P均=0.000);NLR的曲线下面积为0.814, 95%CI为(0.688~0.851),临界值为2.01,灵敏度88.4%、特异度43.1%;PLR的曲线下面积为0.809, 95%CI为(0.704~0.864),临界值为148.63,灵敏度80.6%、特异度46.7%。

结论

术前NLR、PLR对于胃癌患者淋巴结转移具有较高的预测价值,可作为术前淋巴结转移预测指标。

Objective

To analyze the value of preoperative neutrophil / lymphocyte ratio and platelet/lymphocyte ratio in predicting lymph nodes metastasis of patients with gastric cancer.

Methods

Clinical data of 103 patients with gastric cancer treated in our hospital from January 2016 to June 2018 were analyzed retrospectively. According to the pathological results, they were divided into lymph node metastasis group (39 cases) and no lymph node metastasis group (64 cases). Spss20.0 softwarewas used for data analysis.Measurement data such as preoperative inflammation index, NLRand PLR were presented as mean+ standard deviation and were examined by using t test. TNM staging and other count data were compared with χ2 test. To draw the ROC curve and calculate the critical value of NLR, PLR. P<0.05 was considered assignificant difference.

Results

There was no significant difference of white blood cell count betweentwo groups before operation (P=0.156). However, the neutrophils, platelets and lymphocytes in preoperative lymph node metastasis group were higher than those without lymph node metastasis group respectively with significant difference (P=0.037, 0.044, 0.047). The NLR and PLR ofpatients withlymph node metastasis was significantly higher than those of patients without lymph node metastasis, with significant difference (P=0.000). In terms of NLR, the area under the curvewas 0.814, the 95%CI was (0.688±0.851), the critical value was 2.01, the sensitivity was 88.4%, and the specificity was 43.1%. In terms of PLR The area under the curve of PLR was 0.809, 95% CI was (0.704~0.864), the critical value was 148.63, the sensitivity was 80.6%, and the specificity was 46.7%.

Conclusion

Preoperative NLR and PLR have potential value in predicting lymph node metastasis of patients with gastric cancer.

表1 103例胃癌患者根据淋巴结是否转移两组患者一般临床资料比较(例)
表2 103例胃癌患者根据淋巴结是否转移两组患者术前各炎症指标比较(±s)
图1 胃癌患者NLR、PLR和淋巴结转移关系ROC曲线
表3 103例胃癌患者NLR、PLR和淋巴结转移关系的ROC曲线图结果
[1]
Guo J, Yu W, Su H, et al.Genomic landscape of gastric cancer: molecular classification and potential targets[J].Science China Life Sciences, 2017, 60 (2),126-137.
[2]
陈永旭,王昌俊.肿瘤相关巨噬细胞介导的炎性微环境对肝癌干细胞影响的研究进展[J].肿瘤,2017,37(9):989-994.
[3]
赵士菊.肿瘤相关脂肪细胞分泌的脂肪因子、炎性因子和代谢产物对恶性肿瘤促进作用的研究进展[J].当代医药论丛,2017,15(21):1-2.
[4]
杨柳,卢高峰,刘宗文,等.NLR、LMR和PLR与食管鳞癌患者预后的关系[J].安徽医科大学学报,2018,53(3):415-419.
[5]
赵忠治,王金淼,魏颖,等.术前外周血NLR与PLR对胃癌预后的评估价值[J].天津医科大学学报,2018,24(1):50-54.
[6]
全雄男,朴美华,刘兰.术前NLR与PLR对结直肠癌预后的意义[J].中国肿瘤外科杂志,2016,8(6):369-372.
[7]
杜晓辉,胡时栋.腹腔镜胃癌根治术保脾脾门淋巴结清扫术技巧及意义[J/CD].中华普外科手术学杂志(电子版),2018,12(2):95-98.
[8]
杜晓娅.膳食纤维肠内营养对结直肠癌术后炎症反应、抗肿瘤免疫应答的影响[J].海南医学院学报,2018,24(4):504-507,511.
[9]
苏欢,陈明.炎症反应与肿瘤微环境对前列腺癌作用机制的研究进展[J].东南大学学报(医学版),2017,36(5):847-851.
[10]
王婷婷.肿瘤激活的中性粒细胞通过GM-CSF-PD-L1通路抑制抗胃癌免疫并促进胃癌进展[D].重庆:第三军医大学,2017.
[11]
史琳,张宁,赵磊,等.中性粒细胞分泌MMP-2和MMP-9发挥促肿瘤作用[J].免疫学杂志,2018,34(3):214-219.
[12]
高肇妤,梁迪,靳晶,等.中性粒细胞在肺癌发展及预后中的作用[J].肿瘤,2017,37(8):889-894.
[13]
尹超,余红岚,杨梅,等.IL-6与P-选择素在非小细胞肺癌中的表达及临床意义[J].贵州医药,2017,41(6):578-580.
[14]
尹超,余红岚,喻云平,等.非小细胞肺癌患者外周血P-选择素、IL-6、TPO水平及血小板的相关性[J].贵州医科大学学报,2017,42(6):718-722.
[15]
黄国林,滕翠芳,罗燕妹,等.肝细胞肝癌患者癌组织中Ras相关C3肉毒素底物1、转化生长因子β1表达变化及其意义[J].山东医药,2018,58(15):58-60.
[16]
王莉新,吴文斌.NK细胞的免疫监视作用及肿瘤免疫逃逸[J].细胞与分子免疫学杂志,2017,33(3):418-422.
[17]
陈小林,姚国强,刘剑荣.术前外周血中NLR、d-NLR、PLR和LMR四种比值在结直肠癌患者预后诊断中的价值[J].中国免疫学杂志,2015,31(10):1389-1393.
[1] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[2] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[3] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[4] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[5] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[6] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[7] 奚玲, 仝瀚文, 缪骥, 毛永欢, 沈晓菲, 杜峻峰, 刘晔. 基于肌少症构建的造口旁疝危险因素预测模型[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 48-51.
[8] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[9] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[10] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[11] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[12] 张龙, 孙善柯, 徐伟, 李文柱, 李俊达, 池涌泉, 何广胜, 成峰, 王学浩, 饶建华. 腹腔镜脾切除治疗血液系统疾病的临床疗效分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 870-875.
[13] 韦巧玲, 黄妍, 赵昌, 宋庆峰, 陈祖毅, 黄莹, 蒙嫦, 黄靖. 肝癌微波消融术后中重度疼痛风险预测列线图模型构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 715-721.
[14] 蔡晓雯, 李慧景, 丘婕, 杨翼帆, 吴素贤, 林玉彤, 何秋娜. 肝癌患者肝动脉化疗栓塞术后疼痛风险预测模型的构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 722-728.
[15] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
阅读次数
全文


摘要